放射性粒子近距离治疗前列腺癌:临床篇

王俊杰

放射性粒子近距离治疗前列腺癌:临床篇

王俊杰

文章导航 > 国际放射医学核医学杂志 > 2002, 26 > 3: (101-104)

引用本文:

Citation:

放射性粒子近距离治疗前列腺癌:临床篇

王俊杰

100034 北京, 北京大学第三医院肿瘤治疗中心

作者简介: 王俊杰(1964-),男,内蒙古人,副主任医师,副教授,硕士研究生导师,主要从事放射性粒子种植治疗肿瘤和大剂量照射对血管平滑肌细胞抑制作用机制的研究。;

中图分类号: R817.5;R737.25

Radioactive seed implantation treatment for prostate carcinoma

WANG Jun-jie

Department of Radiation Oncology, Peking University 3 rd Hospital, Beijing 100034, China
CLC number: R817.5;R737.25

摘要: 放射性粒子种植治疗前列腺癌是近20年发展起来的新技术,尤其是近5年,由于超声或CT引导介入,计算机三维治疗计划系统指导,使这一技术具有疗效高、创伤小、并发症发病率低等优势,临床应用发展十分迅猛。
- 放射性粒子 /
- 近距离治疗 /
- 前列腺癌
Abstract: There are total 20 years for radioactive seed implantation treatment for prostate carcinoma, especiately recent 5 years. Ultrosound or CT guidance plus computer treatment planning system make the seed implantation become more effective, minidamage and low risk of complications, it become more and more popular in clinical treatment for cancer patients.
- radioactive seed /
- brachytheray /
- prostate carcinoma
本作品遵循Signature-Non-Commercial Use 4.0 International (CC BY-NC 4.0)协议

[1]	Vicini FA,Horwitz EM,Gonzalez J. Treatment options for localized prostate cancer based upon pretreatment prostate specific antigen levels[J].Journal of Urology,1997,(2):319-325.
[2]	Vicini FA,Horwitz EM,Kini VR. Radiotherapy options for localized prostate cancer based upon pretreatment serum prostate specific antigen levels and biochemical control:A comprehensive review of the literature[J].International Journal of Radiation Oncology,Biology,Physics,1998.1101-1110.
[3]	Horwitz EM,Vicini FA,Ziaja EL. Assessing the variability of outcome for patients treated with localized prostate irradiation using different definitions of bioeheroieal control[J].International Journal of Radiation Oncology,Biology,Physics,1996.565-575.
[4]	Hilaris RS. Brachytherapy in cancer of the prostate:an historical perspective[J].Seminars in Surgical Oncology,1997.399-405.
[5]	Vicini FA,Kini VR,Edmundson G. A comprehensive review of prostate cancer brachytherapy:difining an optimal technique[J].International Journal of Radiation Oncology,Biology,Physics,1999,(3):483-491.
[6]	Blasko JC,Wallner K,Grimm PD. Prostate specific antigen based disease control following ultrasound guided 125-iodine implantation for stage T1/T2 prostatic carcinoma[J].Journal of Urology,1995.1096-1099.
[7]	Mate TP,Gottesman JE,Hatton J. High dose-rate afterloading 192-iridium prostate brachytherapy:Feasibility report[J].International Journal of Radiation Oncology,Biology,Physics,1998.525-533.
[8]	Wallner K,Roy J,Harrison L. Tumor control and morbidity following transperineal iodine 125 implantation for stage T1/T2 prostatic carcinoma[J].Journal of Clinical Oncology,1996.449-453.
[9]	Prestige BR,Bite WS,Kiefer EJ. Timing of computerd tomography-based postimplant assessment following permanent transperineal prostate brachytherspy[J].International Journal of Radiation Oncology,Biology,Physics,1998.1111-1115.
[10]	Blasko JC,Radge H,Grim PD. Transperineal ultrosoundguided implantation of the prostate:mobidity and complication[J].Scandinavian Journal of Urology and Nephrology,1991.113-118.
[11]	Nori D,Moni FJ. Current issues in techniques of prostate brachytherapy[J].Seminars in Surgical Oncology,1997.444-453.
[12]	Parker SL,Tong T,Bolden S. Cancer statistics,1997[J].Ca Journal of Clin,1997.5-27.

[1]	王俊杰 , 张占春 . 放射性粒子近距离治疗眼部肿瘤. 国际放射医学核医学杂志, 2002, 26(1): 29-32.
[2]	秦岚 . 前列腺癌近距离放射治疗的进展. 国际放射医学核医学杂志, 2005, 29(4): 159-161.
[3]	王济东 , 王俊杰 . 胰腺癌组织间近距离放射治疗的研究进展. 国际放射医学核医学杂志, 2006, 30(3): 182-184.
[4]	王宇 . 间质植入近距离照射治疗前列腺癌. 国际放射医学核医学杂志, 2001, 25(5): 233-236.
[5]	廖安燕 , 王俊杰 . 持续低剂量率照射治疗前列腺癌的生物学效应. 国际放射医学核医学杂志, 2005, 29(4): 190-192,封三.
[6]	田素青 . 放射性粒子永久植入治疗非小细胞肺癌的研究. 国际放射医学核医学杂志, 2007, 31(3): 188-191.
[7]	陈立波 . 钠/碘同向转运体与放射性碘治疗. 国际放射医学核医学杂志, 2001, 25(6): 258-261.
[8]	陆汉魁 , 林祥通 , 刘家慧 , 林汉 . 乳腺癌和前列腺癌的类固醇受体显像研究现状. 国际放射医学核医学杂志, 1996, 20(3): 106-109.
[9]	郝玉美 , 贺欣 , 宋娜玲 . 前列腺癌干细胞分离方法研究进展. 国际放射医学核医学杂志, 2013, 37(5): 296-300. doi: 10.3760/cma.j.issn.1673-4114.2013.05.011
[10]	马蕊 , 张良安 . 高剂量率近距离放射治疗前列腺癌. 国际放射医学核医学杂志, 2007, 31(3): 191-193.